Importantly, in humans, the fraction of GM-CSF-positive (and IFN-γ-positive) cells within CD4 T cells was elevated in MS patients' cerebrospinal fluid compared to controls, while IL-17A-positive cell fractions were not strikingly different in these reports [11, 12]. This evidence concerns the gene IL17A and myeloid sarcoma.